Hikma Shares Dip Amid Market Pullback, Still Strong Pharma OutlookHikma Pharmaceuticals PLC’s share dip reflects market pullback, not fundamentals. Dual specialty‑drug and generic strategy keeps long‑term value stable.Hikma Pharmaceuticals PLC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Dr. Michael Chen 08/02/2026, 21:38 4 minutes to read